Tying Medicare drug prices to international benchmarks will lower patient costs without reducing access to treatments

International reference pricing could finally close the gap between what Americans and patients in other developed countries pay for the same drugs.

From the articleCMS Finalizes New Mandatory Drug Payment Model to Deliver Lower Drug Prices for Beneficiaries in Original Medicare Part BAlso in Trump Administration Finalizes Plan to Lower Drug Prices in Medicare, CMS finalizes model that aims to bring most-favored nation pricing to Part B, Trump's watered-down Medicare drug pricing rule saves 96% less than initial proposal